NL-OMON36929已完成3 期
Does antenatal allopurinol during perinatal asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? A double blind randomised placebo controlled multicenter trial. - ALLO-trial
niversitair Medisch Centrum Utrecht0 个研究点目标入组 220 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •Pregnant women with a gestational age of at least 36 weeks, suspicion of fetal distress / intra-uterine asphyxia
排除标准
- •Congenital, chromosomal or syndromal malformations.
研究者
相似试验
进行中（未招募）
不适用
Does antenatal allopurinol during asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? - ALLO-trialPerinatal asphyxiaMedDRA version: 9.1Level: LLTClassification code 10004943Term: Birth asphyxiaMedDRA version: 9.1Level: LLTClassification code 10014633Term: Encephalopathy neonatalEUCTR2006-005796-18-NLWKZ / UMC Utrecht
已完成
不适用
Perinatal allopurinol trial for reduction of birth asphyxia induced brain damage.perinatal asphyxia, neuroprotection, allopurinol, newborn, oxidative stressNL-OMON28692Prof dr. F. van Bel220
Unknown
3 期
Antenatal Allopurinol During Fetal HypoxiaFetal HypoxiaReperfusion InjuryNCT00189007UMC Utrecht222
招募中
不适用
Early versus Late Allopurinol Initiation in an Acute Gout Attack: A Randomized Controlled Trial (ELAG)acute gout attack within 72 hours after onsetAllopurinol,Initiation,Gout,Gout outcome.TCTR20190223001avamindradhiraj University Research Fund114
进行中（未招募）
不适用
Evaluación de la utilidad del alopurinol en la prevención de la morbimortalidad cardiovascular de los pacientes con enfermedad renal crónica (ERC) e hiperuricemiaEVALUATION OF THE USE OF ALLOPURINOL IN THE PREVENTION OF CARDIOVASCULAR MORBIMORTALITY IN PATIENTS WITH CHRONIC KIDNEYEnfermedad renal crónica (ERC) e hiperuricemiaMedDRA version: 9.1Level: LLTClassification code 10020907Term: HyperuricemiaMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureEUCTR2007-006994-10-ESFundación Investigación Biomédica Hospital Príncipe de Asturias